<< [Back to News Release Archive]

Raytheon Conducts Free-Flight Demonstration of JSOW-C From F-16IN

BENGALURU, India, Feb. 10, 2011 /PRNewswire/ -- Raytheon Company (NYSE: RTN) completed a series of free-flight demonstrations of the Joint Standoff Weapon (JSOW) AGM-154-C from an F-16IN fighter aircraft. The tests were part of the Indian Air Force's Medium Multi-Role Combat Aircraft (MMRCA) competition.

JSOW is a family of low-cost, air-to-ground weapons that employs an integrated GPS- inertial navigation system and terminal infrared seeker that guide the weapon to the target. The system has a maximum range of 130 kilometers (80.5 statute miles) from high altitude and can penetrate more than 1.5 meters (approximately 5 feet) of reinforced concrete.

"We conducted the demonstration to show that JSOW-C, which is currently integrated on various F-16 international aircraft, could be easily, affordably and rapidly integrated on the F-16IN," said Phyllis McEnroe, Raytheon's JSOW program director. "JSOW is already integrated on the F/A-18 Super Hornet and has been employed from that platform numerous times, so this test proves that JSOW can now be employed from both U.S. MMRCA offerings."

The MMRCA program is a competition to procure 126 new aircraft for Indian air warriors.

Raytheon Company, with 2010 sales of $25 billion, is a technology and innovation leader specializing in defense, homeland security and other government markets throughout the world. With a history of innovation spanning 89 years, Raytheon provides state-of-the-art electronics, mission systems integration and other capabilities in the areas of sensing; effects; and command, control, communications and intelligence systems, as well as a broad range of mission support services. With headquarters in Waltham, Mass., Raytheon employs 72,000 people worldwide.

Contact:


Mike Nachshen (Bengaluru)

John Patterson (Tucson)

+1.520.269.5697

520.794.4459



SOURCE Raytheon Company

SHARE CONTENT

The content of this News Release Archive is historical content. See this
important information regarding such content.

Top of the Page